Figure 1From: Predictors of durable no evidence of disease status in de novo metastatic inflammatory breast cancer patients treated with neoadjuvant chemotherapy and post-mastectomy radiationActuarial disease outcomes for patients treated with neoadjuvant chemotherapy, modified radical mastectomy, and post-mastectomy radiation therapy. (A) overall survival rate, (B) progression-free survival after PMRT, and (C) locoregional control rate.Back to article page